STEMI - ST Elevation Myocardial Infarction Clinical Trial
Official title:
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
Rupture of a coronary artery plaque leads to thrombotic occlusion of the coronary artery and would present as ST segment elevation myocardial infarction. Early treatment with aspirin and early primary percutaneous coronary intervention are indicated. Anticoagulation therapy, usually with unfractionated heparin, is required during percutaneous coronary intervention. Investigators hypothesis is that pretreatment with unfractionated heparin in addition to aspirin at first medical contact may facilitate spontaneous reperfusion of culprit artery and procedural thrombotic complication in patients with ST elevation myocardial infarction without significant risk of bleeding complications.
Randomization of patients with STEMI at first medical contact in a 1:1 ratio into an intervention group receiving 100 IU of unfractionated heparin (UFH) per kilogram of body weight IV and later additionally UFH after diagnostic coronary angiography according to the activated clotting time (ACT) and a control group receiving only UFH after diagnostic coronary angiography at the dose of 100 IU per kilogram of body weight. The primary end point of the study is TIMI flow at coronary angiography. Secondary endpoints are: Bleeding complications (defined by BARC score), occurrence of cardiogenic shock, and 30-day mortality. Investigators plan to randomize 600 patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Terminated |
NCT04542889 -
Coronary Microcirculation Assessment After Primary Angioplasty in Myocardial Infarction
|
N/A | |
Recruiting |
NCT04951856 -
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
|
Phase 4 | |
Terminated |
NCT04459299 -
CorPath GRX STEMI Study
|
||
Recruiting |
NCT05557019 -
Semi Occlusion of the Coronary Sinus as an Adjunct to PCI in STEMI Patients, FIH Clinical Study
|
N/A | |
Completed |
NCT03527940 -
Prognostic Markers of Patients With STEMI
|
||
Not yet recruiting |
NCT03264859 -
NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
|
N/A | |
Not yet recruiting |
NCT03182855 -
Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
|
Phase 4 | |
Not yet recruiting |
NCT03266289 -
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
|
N/A | |
Withdrawn |
NCT04566289 -
Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
|
||
Completed |
NCT04289012 -
HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study
|
N/A | |
Not yet recruiting |
NCT04185077 -
Bivalirudin in Late PCI for Oatients With STEMI
|
Phase 4 | |
Completed |
NCT03609346 -
Asian Registry of the BioFreedom Stent for STEMI Patients
|
||
Recruiting |
NCT05107076 -
Effect of PPCI on Diastolic Function & Levels of Galactin-3 in Patients With STEMI
|
||
Recruiting |
NCT02998853 -
Non Culprit Functional Evaluation With 3D Angio QFR in STEMI PCI Procedure
|
N/A | |
Completed |
NCT03677180 -
National Cardiogenic Shock Initiative
|
||
Completed |
NCT03507777 -
ILUMIEN IV: OPTIMAL PCI
|
N/A | |
Recruiting |
NCT03863327 -
EKG Criteria and Identification of Acute Coronary Occlusion
|
||
Completed |
NCT03070496 -
Multicenter Cohort of STEMI Patients
|
N/A | |
Active, not recruiting |
NCT03874338 -
CLEAR SYNERGY Neutrophil Substudy
|